Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, and Lymphoma Diagnosis and Treatment.
Comparative outcome and prognostic factor analysis among MDS/AML patients with TP53 mutations, snps, and wild type
Development and validation of a prognostic staging system for primary plasma cell leukemia
[Severe pneumonia, intracranial infection, and reversible splenial lesion syndrome caused by <i>chlamydia psittacosis</i> infection].
Updated survival outcomes of pomalidomide/bortezomib/dexamethasone in newly diagnosed multiple myeloma with renal impairment: A prospective, open-label, multicenter, phase 2 study
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD
Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd
Real‐world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis
684P Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC)
The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study
441P The prophylactic efficacy of telpegfilgrastim, a Y-shape branched pegylated G-CSF in patient with chemotherapy-induced neutropenia: A multicenter, randomized phase III study
Comprehensive Analysis of Baseline Risk Factors Associated with Poor Outcomes and Development of the First Staging System for Primary Plasma Cell Leukemia: A Retrospective, Multicenter, Cohort Study
Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes
Lymph Node Fibroblastic Reticular Cells Attenuate Immune Responses Through Induction of Tolerogenic Macrophages at Early Stage of Transplantation
The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma
A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe
Oligosecretory Waldenström Macroglobulinemia Patients Exhibit Excellent Treatment Response and Outcomes
Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study
Waldenström's Macroglobulinaemia in the Modern Era: Real World Outcomes and Prognostication across 35 Chinese Academic Hospitals